A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
NCT05496335
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
AGN-151586
DRUG:
BOTOX
DRUG:
Placebo
Sponsor
AbbVie